Schreiber W E, Sadro L C
Department of Pathology, Vancouver General Hospital, British Columbia, Canada.
Am J Clin Pathol. 1988 Aug;90(2):181-6. doi: 10.1093/ajcp/90.2.181.
The clinical value of alkaline phosphatase isoenzyme analysis is limited by the inability of most electrophoretic methods to resolve the liver and bone isoenzymes. The authors attacked this problem by treating serum samples with neuraminidase, then running treated and untreated samples side-by-side on specially prepared agarose gels. Each isoenzyme showed a characteristic mobility before and after neuraminidase treatment that allowed its identification. The mobility of the bone isoenzyme was most affected, whereas the intestinal isoenzyme was resistant to the action of neuraminidase. In samples with both liver and bone isoenzymes, pretreatment with neuraminidase clearly distinguished the bands, allowing quantitation by densitometry. Using this method, the authors discovered 22 liver isoenzymes in 54 samples that were interpreted as only bone isoenzyme before neuraminidase treatment. They also detected two bone isoenzymes in 35 samples that appeared to contain only liver +/- biliary isoenzymes. In addition, this procedure enabled them to characterize several unusual isoenzymes with respect to mobility, thus avoiding confusion with the other isoenzymes.
碱性磷酸酶同工酶分析的临床价值受到限制,因为大多数电泳方法无法分辨肝脏和骨骼同工酶。作者通过用神经氨酸酶处理血清样本,然后将处理过的样本和未处理的样本在特制的琼脂糖凝胶上并排进行电泳,来解决这个问题。每种同工酶在神经氨酸酶处理前后都显示出特征性的迁移率,从而可以进行鉴定。骨骼同工酶的迁移率受影响最大,而肠道同工酶对神经氨酸酶的作用具有抗性。在同时含有肝脏和骨骼同工酶的样本中,用神经氨酸酶预处理能清晰地区分条带,从而可以通过光密度法进行定量分析。使用这种方法,作者在54个样本中发现了22种肝脏同工酶,这些样本在神经氨酸酶处理前被认为只含有骨骼同工酶。他们还在35个似乎只含有肝脏+/-胆汁同工酶的样本中检测到了两种骨骼同工酶。此外,这个程序使他们能够根据迁移率对几种不寻常的同工酶进行表征,从而避免与其他同工酶混淆。